PET/CT is a cost-effective tool against cancer: synergy supersedes singularity

Barbara Malene Fischer; Barry A. Siegel; Wolfgang A. Weber; Konrade von Bremen; Thomas Beyer; Antonis Kalemis

doi:10.1007/s00259-016-3414-5

PET/CT is a cost-effective tool against cancer: synergy supersedes singularity

Barbara Malene Fischer, Barry A. Siegel, Wolfgang A. Weber, Konrade von Bremen, Thomas Beyer^*, Antonis Kalemis

^*Corresponding author af dette arbejde

Institut for Klinisk Medicin

9 Citationer (Scopus)

39 Downloads (Pure)

Originalsprog	Engelsk
Tidsskrift	European Journal Of Nuclear Medicine
Vol/bind	43
Udgave nummer	10
Sider (fra-til)	1749-1752
Antal sider	4
ISSN	0340-6997
DOI	https://doi.org/10.1007/s00259-016-3414-5
Status	Udgivet - 2016

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1007/s00259-016-3414-5Licens: CC BY

PET/CT is a cost-effective tool against cancer: synergy supersedes singularityForlagets udgivne version, 240 KBLicens: CC BY

Citationsformater

@article{350a37c796de424b897dc13443c93531,

title = "PET/CT is a cost-effective tool against cancer: synergy supersedes singularity",

author = "Fischer, {Barbara Malene} and Siegel, {Barry A.} and Weber, {Wolfgang A.} and {von Bremen}, Konrade and Thomas Beyer and Antonis Kalemis",

year = "2016",

doi = "10.1007/s00259-016-3414-5",

language = "English",

volume = "43",

pages = "1749--1752",

journal = "European Journal Of Nuclear Medicine",

issn = "0340-6997",

publisher = "Springer",

number = "10",

}

TY - JOUR

T1 - PET/CT is a cost-effective tool against cancer

T2 - synergy supersedes singularity

AU - Fischer, Barbara Malene

AU - Siegel, Barry A.

AU - Weber, Wolfgang A.

AU - von Bremen, Konrade

AU - Beyer, Thomas

AU - Kalemis, Antonis

PY - 2016

Y1 - 2016

U2 - 10.1007/s00259-016-3414-5

DO - 10.1007/s00259-016-3414-5

M3 - Editorial

C2 - 27178271

AN - SCOPUS:84968531396

SN - 0340-6997

VL - 43

SP - 1749

EP - 1752

JO - European Journal Of Nuclear Medicine

JF - European Journal Of Nuclear Medicine

IS - 10

ER -